HR+/HER2- Early Breast Cancer

Explore clinical trials studying HR+/HER2- Early Breast Cancer. Study availability and eligibility vary by location and protocol.

6 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

HR+/HER2- Early Breast Cancer trial results

Recruiting

NCT07708571

Conditions: HR+/HER2- Early Breast Cancer
Locations: Department of Gynecology and Obstetrics, Universitätsklinikum Augsburg Augsburg, Bavaria, Germany

Department of Obstetrics and Gynecology, Uniklinikum Erlangen Erlangen, Bavaria, Germany

MVZ Klinikum Aschaffenburg, Zweigstelle Hänatologie und Onkologie Hösbach, Bavaria, Germany

Recruiting

NCT06797531

Conditions: Breast Diseases, Breast Neoplasms, HR+/HER2- Early Breast Cancer, +4 more
Locations: Novartis Investigative Site Riyadh, Saudi Arabia

Novartis Investigative Site Riyadh, Saudi Arabia

Recruiting

NCT07616453

Conditions: HR+/HER2- Early Breast Cancer
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

Recruiting

NCT07531693

Conditions: HR+/HER2- Early Breast Cancer
Locations: Department of Obstetrics and Gynaecology, Uniklinikum Erlangen Erlangen, Bavaria, Germany

Not Yet Recruiting

NCT07521202

Conditions: HR+/HER2- Early Breast Cancer
Locations: Department of Obstetrics and Gynaecology Erlangen, Bavaria, Germany

Completed

NCT07162051

Conditions: Breast Diseases, Breast Neoplasms, HR+/HER2- Early Breast Cancer, +4 more
Locations: Xijing hospital Xi'an, Shaanxi, China